Wengui Yu

Dr. Wengui Yu serves as Director of the UCI Health Comprehensive Stroke and Cerebrovascular Center, Clinical Professor in the Department of Neurology, and Vice Chair for Hospital Affairs at the University of California, Irvine School of Medicine. Board-certified in Vascular Neurology, Neurology, and Neurocritical Care, he leads one of the nation's premier stroke programs with expertise in complex cerebrovascular disorders.

His educational background includes:

• Medical Degree: Jiangxi Medical College, China
• PhD in Experimental Medicine: McGill University, Canada
• Neurology Residency: University of Missouri-Columbia
• Neurocritical Care & Stroke Fellowship: University of California, San Francisco

Dr. Yu's research focuses on severe stroke outcomes, intracranial atherosclerotic stenosis, traumatic brain injury, and methamphetamine-related cerebrovascular disease. His work bridges clinical practice and translational research, particularly in optimizing endovascular interventions for intracranial stenosis and understanding socioeconomic impacts on stroke care. Recent publications demonstrate leadership in AI-assisted stroke detection and novel trial designs for intracranial artery stenosis.

Key scientific recognition includes:

• 2013 Outstanding Contribution Award from Tiantan International Stroke Conference
• 2010 Honorary Award for International Exchange & Cooperation from China's Ministry of Health

As Principal Investigator for the ASPIRE trial (Anticoagulation in ICH Survivors), he advances stroke prevention strategies while directing neurocritical care programs previously established at University of Texas Southwestern and Cedars-Sinai Medical Center. His clinical practice emphasizes patient-centered communication in both English and Mandarin Chinese.